Close
ACHEMA MIDDLE EAST 2026

Icertis Extends Leadership in Pharmaceutical Market with Update to Clinical Trial Agreement

Icertis, the leading provider of enterprise contract management in the cloud announced an upgrade to the Icertis Clinical Trial Agreement and Budgeting solution designed...

Jazz Pharmaceuticals enrolls first patient in phase 3 clinical study of JZP-258 to treat adult narcolepsy patients

Jazz Pharmaceuticals plc announced that the first patient has been enrolled in a Phase 3 clinical study evaluating JZP-258, an investigational oxybate product candidate...

Catalyst Pharmaceuticals announces ‘positive’ data from Firdapse trial

Catalyst Pharmaceuticals, Inc. , a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare neuromuscular and neurological diseases announced positive...

Apitope announces positive ATX-MS-1467 phase IIa data in relapsing Multiple Sclerosis

Apitope, the drug discovery and development company focused on treating the underlying cause of autoimmune diseases, announces positive results from the Phase IIa clinical...

CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates

CohBar Inc , a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced that it has completed...

Jazz Pharm announces first patient enrolled in phase 2 clinical study evaluating JZP-110

Jazz Pharm announced that the first patient has been enrolled in a Phase 2 clinical study evaluating JZP-110 , a selective dopamine and norepinephrine...

Neuraltus Pharma Provides Enrollment Update on Confirmatory Phase 2 Study of NP001 in ALS

Neuraltus Pharmaceuticals announced the confirmatory Phase 2 study of the Company’s lead investigational treatment NP001 for amyotrophic lateral sclerosis (ALS, also known as Lou...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...